Introduction

Creatine supplementation plays a pivotal role in improving the quality of life for cerebral creatine deficiency syndromes (CCDS). These disorders are associated with errors in creatine metabolism, which can be in the formation of creatine or in its transportation through the body. The benefits and shortcomings of creatine supplementation are closely tied to the specific type of deficiency, accessibility, and the timing of early intervention.¹ 

The following article provides a description and explanation of the use of creatine supplementation in CCDS, looking at both real-world efficacy and limitations. 

Overview

Firstly, creatine is a supplement primarily associated with athletic performance, known to enhance glycogen storage in muscles. Creatine can be found in nature, with some foods having larger amounts, such as red meat, but it can also be easily purchased as a creatine monohydrate supplement over the counter. Although commonly associated with athletic performance, recent research shows the effects of creatine supplementation in creatine deficiency disorders.²

CCDS are associated with three major deficiencies: guanidinoacetate methyltransferase (GAMT) deficiency, L-arginine: glycine amidinotransferase (AGAT) deficiency, and creatine transporter (CRTR) deficiency. Understanding these deficiencies and how they can be addressed through creatine supplementation is vital in managing any disorders caused by them.¹ 

CCDS and medical conditions associated

The three types of CCDS have been associated with the following medical conditions:¹ 

• Developmental delay
• Cognitive impairment
• Intellectual disability 
• Language disorder

Creatine’s role in the brain

Despite the brain accounting for approximately 2% of the body’s entire mass, it uses around 20% of the body’s total energy. This is due to the neurons’ need for adenosine triphosphate (ATP). By the necessary reactions between amino acids arginine, glycine, and methionine, ATP can be synthesised and delivered to the neurons. However, creatine is a compound that is used for synthesising ATP; therefore, a creatine deficiency does not allow the optimum requirements necessary for the correct function of the brain.^3,4

Efficacy by disorder type

GAMT and AGAT deficiency are inherited disorders as they are recessive conditions. Ultimately, this means if both parents were to be carriers for the condition, but not affected, each child of those parents would have a 25% chance of inheriting the deficiency. It has been shown that oral creatine monohydrate supplementation replenishes creatine levels within the brain, helping to manage behavioural manifestations.^1,3,4

CRTR deficiency has been treated like a creatine deficiency, with oral creatine monohydrate supplementation playing a major role, as well as ornithine supplementation and dietary arginine restriction.¹

Considering both the availability and affordability of a creatine monohydrate supplement, the efficacy of creatine supplementation for CCDS is reasonable. With creatine being available in most major retailers, online, and elsewhere, for prices ranging from around £10 to £20, and quantities ranging from 100g to 1kg and sometimes more, creatine supplementation usually would not pose a problem for most people. However, it is important to highlight that this supplementation must be consulted and approved by a GP.

Limitations of creatine therapy

Although seemingly affordable to the majority of people, not everyone will be financially able to purchase a creatine supplement. Many families would prioritise other bare necessities over buying a creatine monohydrate supplement, such as food, clean water, baby food, hygiene products, and others. When considering this, buying or even having access to a creatine monohydrate supplement is the least of some people’s worries. Moreover, the limitation could be due to a lack of knowledge and education about the condition. Many people may not have even heard of CCDS.

Combination therapies and emerging research

A 2022 study showcased the effects of a combination therapy on 28 CCDS-affected people, in which combined supplementation of creatine, arginine, and glycine improved cognitive function, developmental function, and other manifestations.⁵

Due to CCDS being an inherited condition, gene therapy is at the forefront of emerging research to not only manage behavioural manifestations, but prevent them altogether. Most notably, viral vectors serve as a mechanism to edit genes in which desirable genes can be incorporated into affected persons’ genetic code. Adeno-associated viruses (AAV) have been the most promising in delivering desirable therapeutic genes, as they do not show negative immune or inflammatory responses commonly associated with viral vectors. AAV have shown promising results in the clinical trials of other conditions, such as Parkinson’s disease. Although limitations can occur with viral vectors, mainly regarding the size of the genome that can be delivered, it still serves as a promising area of emerging research.⁵

FAQs

How does creatine work?

The compound creatine is found in foods, such as red meat and is available over the counter as a supplement. This plays a role in the production of the body's main energy currency, ATP, which supports muscle function and brain activity.

How do these cerebral creatine deficiency syndromes occur?

CCDS are rare genetic disorders caused by creatine synthesis or transport problems. These include GAMT deficiency, AGAT deficiency, and CRTR deficiency.

How does creatine help CCDS?

During GAMT and AGAT deficiencies, oral creatine monohydrate can replenish brain creatine, preventing further decline. CRTR deficiency requires dietary changes along with other supplements.

Can creatine cure CCDS?

No. Many symptoms and quality of life improve with creatine, but many of them require ongoing specialist support.

Limitations of creatine therapy?

Barriers include low awareness of CCDS, limited access in low-resource settings, and financial constraints for some families.

Future of CCDS treatment?

Creatine supplementation remains the mainstay for some CCDS types, but emerging gene therapies may one day eliminate symptoms.

Summary

For athletic performance and brain energy metabolism, creatine is needed. Defects in creatine synthesis or transport - GAMT, AGAT, or CRTR deficiencies - cause developmental delays, cognitive impairment, speech disorders, and movement problems in CCDS. In GAMT and AGAT deficiencies, supplemental creatine monohydrate restores brain creatine and relieves symptoms; in CRTR deficiency, dietary measures are needed. Beneficiaries include improved life expectancy and prevention of further decline, although some impairments require specialist care. Global accessibility, competing priorities, and lack of awareness limit treatment despite its low cost and availability in many regions. Emerging combination therapies and gene editing promise broader, long-term solutions.